Breast Cancer :: Bevacizumab and chemotherapy improve breast cancer
Preliminary results from a large, randomized clinical trial for patients with previously untreated recurrent or metastatic breast cancer – cancer that has spread from the breast to other parts of the body – show that those patients who received bevacizumab (Avastin) in combination with standard chemotherapy had a longer time period before their cancer progressed than patients who received the same chemotherapy without bevacizumab.